Here are the first few paragraphs of a December 31 Guardian article (“Palestinian superbug epidemic could spread, say doctors”) by Madlen Davies and Emma Graham-Harrison:
Doctors in Gaza and the West Bank have said they are battling an epidemic of antibiotic-resistant superbugs, a growing problem in the world’s conflict zones, which could also spill over the Palestinian borders.
The rise and spread of such virulent infections adds to the devastation of war, increasing medical costs, blocking hospital beds because patients need care for longer, and often leaving people whose injuries might once have been healed with life-changing disabilities.
Gaza is a particularly fertile breeding ground for superbugs because its health system has been worn down by years of blockade, and antibiotics are in short supply, the Bureau of Investigative Journalism has found.
Even though doctors in Gaza knew protocols to prevent the rise of drug-resistant bacteria, persistent shortages of antibiotics meant they could not always follow them, they told reporters. Patients take incomplete courses of antibiotics or are prescribed a mix because the right medicine is not available.
The rest of the 1,000-plus word piece follows this pattern of suggesting that Israel is largely to blame for the shortage of vital medicines in Gaza — a shortage that is putting the lives of countless Palestinians at risk.
But that is a lie. The import of antibiotics and almost all other important medicines are not in any way impacted by Israel’s blockade. As a CAMERA-prompted correction at The New York Times noted, “the import of medicine” to Gaza “is not restricted” by Israel.